Sterling
GSK logo
GSK
BioNTech logo
BioNTech

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q2 2026: GSK 10.595, BioNTech 0.114.

GSK vs BioNTech Net Worth and Market Cap

GSK (GSK) and BioNTech (BNTX) are peers in Vaccines. GSK reported revenue of $10.6B as of Q2 2026, compared with $114M for BioNTech. GSK leads on revenue.

GSK's gross margin is 73.0% versus 8.1% for BioNTech. GSK's net margin is 5.2% versus -777.3% for BioNTech.

Key differences

  • Revenue growth from Q2 2025 to Q2 2026: GSK +5.3%, BioNTech -59.6%.
  • GSK made an operating profit in its latest quarter (5.7% margin); BioNTech made an operating loss (-897.8%).
  • GSK's KPIs on Sterling include Arexvy Sales by Region (Quarterly) and HIV Franchise Sales (Quarterly).
  • BioNTech's KPIs on Sterling include Cash, Cash Equivalents, and Security Investments (Quarterly) and COMIRNATY Doses as Printed.

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, GSK, BioNTech.
MetricGSKBioNTech
Market Cap--
Revenue$10.60B$114.00M
Cost of Revenue$2.85B$105.00M
Gross Profit$7.74B$9.00M
Operating Income$606.00M$-1.02B
Net Income$548.00M$-886.00M
R&D Expense$4.37B$595.00M
Earnings Per Share$0.28-$3.5
Gross Margin73.0%8.1%
Operating Margin5.7%-897.8%
Net Profit Margin5.2%-777.3%
Free Cash Flow$2.78B$-48.00M
Cumulative Free Cash Flow$157.21B$19.56B
Operating Cash Flow$3.19B$12.00M
Cash & Equivalents$3.89B$10.52B

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites